Taken together, our data identify CD142 and podoplanin as potential surface markers that are differentially expressed between cells with mutant, active beta-catenin and nonmutant, inactive beta-catenin in heterogeneous desmoid tumor samples. Here, CTNNB1 is linked to neoplasm.